RRM2 and Ewing sarcoma: MYBL2 has been identified as a direct target of EWSR1::FLI1 with germline polymorphisms associated with activation in Ewing sarcoma and RRM2 overexpression is associated with poor prognosis Ewing sarcoma (36, 37).